Enrique Manan

Enrique A. Mañón serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirement validation and market research through contract award and administration. He plays a critical role in ensuring compliance with federal procurement regulations while advancing mission-critical scientific and manufacturing objectives. His portfolio primarily encompasses research and development services and biological product manufacturing contracts, requiring deep technical understanding of biotechnology workflows and Good Manufacturing Practices. He works closely with scientific stakeholders to translate complex requirements into enforceable contract terms that ensure deliverables meet regulatory and performance standards. While no specific contractor relationships are currently identifiable in the data, Mañón’s procurement patterns suggest consistent engagement with firms possessing specialized capabilities in biotechnology R&D and biological manufacturing, including contract research organizations, process development labs, and GMP-certified production facilities. His approach emphasizes technical competence, regulatory adherence, and performance-based outcomes, fostering long-term partnerships with vendors who demonstrate proven expertise in highly regulated environments. Mañón’s contracting activity reflects a strong preference for open competition, with 100% of his acquisitions classified as “No Set-Aside.” This indicates a focus on selecting the most technically qualified offerors regardless of socioeconomic status, though it does not preclude small business participation where firms are best positioned to meet requirements. His approach prioritizes mission effectiveness over socioeconomic targeting, aligning with agency needs that demand specialized scientific capabilities often held by niche, non-traditional contractors. His primary NAICS focus lies in 541714 (Research and Development in Biotechnology), where he procures preclinical studies, process optimization, and analytical method development. Secondary emphasis on 325414 (Biological Product Manufacturing) reflects his involvement in scaling up therapeutic production, including cell-based and protein-based biologics. A minor focus on 327212 (Pressed and Blown Glass Manufacturing) suggests procurement of specialized labware or containment systems for sensitive biological materials, underscoring his technical acumen across interdisciplinary scientific domains.